Showing results (121-130 of 150) with videos related to
Sort By:
Pageof 15
Cancers|August 14, 2025
Multi-Institutional Comparison of Ablative 5-Fraction Magnetic Resonance-Guided Online Adaptive Versus 15/25-Fraction Computed Tomography-Guided Moderately Hypofractionated Offline Adapted Radiation Therapy for Locally Advanced Pancreatic CancerMichael D Chuong, Eileen M O'Reilly, Robert A Herrera, et al.JTO Clinical and Research Reports|September 30, 2021
Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLCAnnemarie F Shepherd, Anthony F Yu, Michelle Iocolano, et al.Advances in Radiation Oncology|January 24, 2022
Factors Associated With Premature Ovarian Insufficiency in Young Women With Locally Advanced Rectal Cancer Treated With Pelvic Radiation TherapyLara Hilal, Andrea Cercek, John Navilio, et al.Annals of Surgery|August 13, 2021
Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal AdenocarcinomaRebecca A Carr, Meier Hsu, Caitlin A Harrington, et al.Journal of Gastrointestinal Oncology|September 17, 2021
Ablative radiation therapy for hepatocellular carcinoma is associated with reduced treatment- and tumor-related liver failure and improved survivalLara Hilal, Marsha Reyngold, Abraham J Wu, et al.Annals of Surgery|February 2, 2023
Waiting to Operate: The Risk of Salvage EsophagectomyThomas Boerner, Caitlin Harrington, Kay See Tan, et al.International Journal of Radiation Oncology, Biology, Physics|July 22, 2025
Development of Second Malignancies Following Chemotherapy With or Without Radiation Therapy for the Treatment of Locally Advanced Rectal CancerKathryn R Tringale, Kush H Patel, Lara Hilal, et al.Journal of the National Cancer Institute|December 3, 2024
Increased occurrence of malignancy before and after chemoradiation for anal squamous cell carcinoma: a multi-institutional analysisRitesh Kumar, Chris L Hallemeier, Daniel T Chang, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 4, 2026
Safety profile of KRAS G12C inhibitors combined with thoracic radiation therapyDavid Gibbes Miller, Y Helen Zhang, Maria Thor, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2025
Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung CancerAndreas Rimner, Benjamin H Lok, Daphna Y Gelblum, et al.Pageof 15